Aura Biosciences, Inc. (AURA) stock
AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.15−0.07 (-0.97%)
Close on Nov 17, 2026Market cap $741.49MP/E –Yield –
Aura Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Aura Biosciences's price to book ratio was 2.5× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 1.6× to 4.5×, with a median of 2.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.5× | +0.3 |
| 2025 | Dec 31, 2025 | 2.2× | −0.2 |
| 2024 | Dec 31, 2024 | 2.3× | +0.1 |
| 2023 | Dec 29, 2023 | 2.2× | −0.4 |
| 2022 | Dec 30, 2022 | 2.7× | – |
See a number that looks wrong?